Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials

Background: Psoriasis is a chronic, immune-mediated skin disease that may occur at any age. Prevalence in children ranges between 0.5 and 1.0% across Europe. Approximately 10–20% of paediatric psoriasis patients are moderate-to-severe in severity and may require the use of systemic therapy. Objectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Lernia, Vito, Macca, Laura, Peterle, Lucia, Ingrasciotta, Ylenia, Trifirò, Gianluca, Guarneri, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017712/
https://www.ncbi.nlm.nih.gov/pubmed/35450044
http://dx.doi.org/10.3389/fphar.2022.847308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017712/
https://www.ncbi.nlm.nih.gov/pubmed/35450044
http://dx.doi.org/10.3389/fphar.2022.847308

Ejemplares similares